Correspondence of parent and teacher reports in medication trials

European Child and Adolescent Psychiatry

Volumn 14, Issue 1, 2005, Pages 20-27

  Faraone, Stephen V ^a,b   Biederman, Joseph ^a   Zimmerman, Brenda ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c McNeil Laboratories Inc   (United States)

Author keywords

ADHD; Medication trials; Parent teacher reports

Indexed keywords

METHYLPHENIDATE; OROS; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPPOSITIONAL DEFIANT DISORDER; PARENTAL BEHAVIOR; PHYSICAL ACTIVITY; PROBABILITY; STATISTICAL SIGNIFICANCE; TEACHER; TEACHING; TREATMENT OUTCOME; CHILD PARENT RELATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FACULTY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JUDGMENT; MALE; OBSERVER VARIATION; PARENTS;

EID: 16344390596     PISSN: 10188827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00787-005-0415-5     Document Type: Article

References (36)

1. Achenbach TM, McConaughty SH, Howell CT (1987) Child/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity. Psychol Bull 101(2):213-232
2. Achenbach TM (1991) Manual for the Child Behavior Checklist/4-18 and the 1991 Profile. Burlington, VT, University of Vermont Department of Psychiatry
3. American Academy of Pediatrics (2000) Clinical Practice Guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105(5):1158-1170
4. th edn. Lippincott Williams and Wilkins, pp 2295-2310
5. Barkley AR (1990) Attention-Deficit/Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guilford Press
6. Barkley RA, Guevremont DC, Anastopoulos AD, Du Paul GJ, Shelton TL (1993) Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics 92(2):212-218
7. Barkley RA, Murphy KR, Kwasnik D (1996) Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 98(6 Pt 1): 1089-1095
8. th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, October 22-27
9. Biederman J, Keenan K, Faraone SV (1990) Parent-based diagnosis of attention deficit disorder predicts a diagnosis based on teacher report. J Am Acad Child Adolesc Psychiatry 29(5):698-701
10. Biederman J, Faraone SV, Milberger S, Doyle A (1993) Diagnoses of attention-deficit hyperactivity disorder from parent reports predict diagnoses based on teacher reports. J Am Acad Adolesc Psychiatry 32(2):315-317
11. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA (2002a) Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 159:36-42
12. Biederman J, Lopez FA, Boellner SW, Chandler MC (2002b) A randomized, double-blind, placebo-controlled, parallel-group study of SL381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics 110(2 Pt 1):258-266
13. DHHS, US Department of Health and Human Services (1999) Mental Health: A Report of the Surgeon General. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute for Mental Health: Rockville, MD
14. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE (2000a) Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 48(1):9-20
15. Faraone SV, Biederman J, Feighner JA, Monuteaux MC (2000b) Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid. J Consult Clin Psychol 68(5):830-842
16. Faraone S, Biederman J (2002) Efficacy of Adderall for attention-deficit/hyperactivity disorder: a meta-analysis. J Atten Disord 6(2):69-75
17. Goyette CH, Conners CK, Ulrich RF (1978) Normative data on revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol 6:221-236
18. Greene RW, Biederman J, Faraone SV, Monuteaux MC, Mick E, DuPre EP, Fine CS, Goring JC (2001) Social impairment in girls with ADHD: patterns, gender comparisons, and correlates. J Am Acad Child Adolesc Psychiatry 40:704-710
19. Loeber R, Green SM, Lahey BB, Stouthhamer-Loeber M (1991) Differences and similarities between children, mothers, and teachers as informants on disruptive child behavior. J Abnorm Child Psychol 19:75-95
20. Loney J, Milich R (1982) Hyperactivity, inattention, and aggression in clinical practice. In: Wolraich M, Routh DK (eds) Advances in Developmental and Behavioral Pediatrics. Greenwich, CT, JAI Press, pp 113-147
21. Mannuzza S, Klein RG, Konig PH, Giampino TL (1989) Hyperactive boys almost grown up. IV. Criminality and its relationship to psychiatric status. Arch Gen Psychiatry 46(12):1073-1073
22. Mitsis EM, McKay KE, Schulz KP, Newcorn JH, Halperin JM (2000) Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample. J Am Acad Child Adolesc Psychiatry 39(3):308-313
23. MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder: the multimodal treatment study of children with ADHD. Arch Gen Psychiatry 56(12):1073-1086
24. Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J (1999a) A comparison of Ritalin and Adderall: efficacy and time-course in children with attention-deficit/ hyperactivity disorder. Pediatrics 103(4):1-14
25. Pelham WE, Gnagy EM, Chronis AM, Burrows-MacLean L, Fabiano GA, Onyango AN, Meichenbaum DL, Williams A, Aronoff HR, Steiner RL (1999b) A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/ hyperactivity disorder. Pediatrics 104(6):1300-1311
26. Pelham WE, Gnagy EM, Burrows-MacLean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fiebelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD (2001) Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107(6):e105
27. Rutter M (1982) Syndromes attributed to "minimal brain dysfunction" in childhood. Am J Psychiatry 139:21-33
28. Rutter M (1988) DSM-III-R: A Post-script. In: Rutter M, Tuma AH, Lann IS (eds) Assessment and Diagnosis in Child Psychopathology. New York, Guilford Press, pp 453-464
29. Schachter HM, Pham B, King J, Langford S, Moher D (2001) How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 165(11):1475-1488
30. Swanson J, Gupta S, Williams L, Agler D, Lerner M, Wigal S (2002) Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground. J Am Acad Child Adolesc Psychiatry 41:1306-1314
31. Touliatos J, Lindholm BW (1981) Congruence of parents' and teachers' ratings of children's behavior problems. J Abnorm Child Psychol 9(3):347-354
32. Verhulst FC, Koot HM, Van der Ende J (1994) Differential predictive value of parents' and teachers' reports of children's problem behaviors: a longitudinal study. J Abnorm Child Psychol 22(5):531-546
33. th Annual Meeting of the American Psychiatric Association, Philadelphia, PA
34. Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M (2003) ADHD treatment with once-daily OROS® methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry 42(4):424-433
35. Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G (2001) Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/ hyperactivity disorder. Pediatrics 108(4):883-892
36. Zeiner P (1987) Parent-reported symptoms of hyperactivity and attention deficits predict teacher-reported symptoms. Acta Paediatr 86(2):178-182